We are live on
!
Find out more
RCAMU
Rothschild & Co Asset Management US Portfolio holdings
AUM
$6.58B
1-Year Est. Return
4.5%
This Fund
S&P 500
This Quarter
Est. Return
+1.39%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
–
AUM
$9.24B
AUM Growth
-$130M
(-1.4%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-2.05%
Top 10 Holdings %
Top 10 Hldgs %
12.25%
Holding
362
New
11
Increased
110
Reduced
214
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kimberly-Clark
KMB
|
+$43.2M |
| 2 |
Textron
TXT
|
+$33.4M |
| 3 |
CF Industries
CF
|
+$30.1M |
| 4 |
Merit Medical Systems
MMSI
|
+$30M |
| 5 |
Glacier Bancorp
GBCI
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$61M |
| 2 |
Essent Group
ESNT
|
+$38.1M |
| 3 |
AGN
Allergan plc
AGN
|
+$35.4M |
| 4 |
Emcor
EME
|
+$28.2M |
| 5 |
Chevron
CVX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.58% |
| 2 | Industrials | 14.58% |
| 3 | Healthcare | 12.79% |
| 4 | Technology | 11.13% |
| 5 | Consumer Discretionary | 8.32% |
Similar funds
GG
AIM
AAM
PG
ZCA
GJIC
SBL
TFS
Rothschild & Co Asset Management US's Q3 2019 Portfolio in Review
As of Q3 2019, Rothschild & Co Asset Management US held 362 positions worth $9.24B, down 1.4% from $9.37B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Rothschild & Co Asset Management US's Q3 2019 filing shows 11 new, 110 increased, 214 reduced and 15 closed positions. Its largest new stake was Kimberly-Clark: 314,002 shares worth $44.6M. The largest sale was Pfizer, an estimated $61M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.
- Rothschild & Co Asset Management US's largest Q3 2019 buy was Kimberly-Clark: 314,002 shares worth $44.6M.
- Rothschild & Co Asset Management US added most to Merit Medical Systems in Q3 2019, an estimated $30M increase.
- Rothschild & Co Asset Management US's biggest Q3 2019 reduction was Pfizer, cutting an estimated $61M.
- Rothschild & Co Asset Management US fully exited Essent Group in Q3 2019, selling an estimated $38.1M.
- Rothschild & Co Asset Management US's ten largest holdings make up 12% of its $9.24B portfolio in Q3 2019.
- Rothschild & Co Asset Management US opened 11 new positions and closed 15 in Q3 2019.
- Rothschild & Co Asset Management US's portfolio value fell 1.4% quarter-over-quarter to $9.24B.
Based on Rothschild & Co Asset Management US's 13F filing for Q3 2019, filed 8 Nov 2019.